(Q27335053)
Statements
A new drug design targeting the adenosinergic system for Huntington's disease (English)
0 references
2011
0 references
6
0 references
e20934
0 references
6
0 references
21 June 2011
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference